HER2陽性・測定可能病変を有さない進行再発胃癌に対するS-1+cisplatin+trastuzumab3週間サイクル併用療法第II相試験(OGSG1202,HERBIS-1B)

2019 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []